DoW Peer Reviewed Medical, Clinical Trial Award

The FY26 Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award (Funding Opportunity Number: HT942526PRMRPCTA) seeks applications for clinical trials with significant impact on disease treatment and management within congressionally directed PRMRP topic areas and strategic goals. Administered by the Defense Health Agency, this grant offers three funding levels (up to $20M) for Phase 0-3 clinical trials, with an optional 12-month planning phase for regulatory activities. Eligibility extends to extramural and intramural U.S. Department of War organizations, with independent investigators as Principal Investigators. Applications must address specific FY26 PRMRP topic areas (e.g., Autoimmune Disorders, Neuroscience, Rare Diseases) and strategic goals (e.g., Prevention, Treatment), demonstrating relevance to military health. The two-step application process involves a pre-application (due July 23, 2026) and a full application (due September 22, 2026) for invited applicants. No preclinical research or animal studies are supported.